Elan reiterated at sell by Citigroup

Citigroup Investment Research analyst Andrew Swanson reiterated Elan Corp. plc at a sell rating. The company will report its fourth-quarter 2005 earnings before the market opens on Jan. 31. Citigroup forecasts a loss of $0.11 per share versus a loss of $0.27 in the fourth quarter of 2004; the consensus estimate is a loss of $0.18. Revenues are forecasted at $137.6 million, an 11% year-on-year increase. Shares of the Dublin, Ireland, biopharmaceutical company were up 43 cents, or 3.05%, at $14.55 on volume of 6,785,500 shares versus the three-month running average of 9,285,130 shares. (NYSE: ELN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.